Invasive meningococcal disease in England and Wales: Implications for the introduction of new vaccines
- 16 March 2012
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 30 (24), 3710-3716
- https://doi.org/10.1016/j.vaccine.2012.03.011
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- The Transposon-Like Correia Elements Encode Numerous Strong Promoters and Provide a Potential New Mechanism for Phase Variation in the MeningococcusPLoS Genetics, 2011
- The Structure ofNeisseria meningitidisLipid A Determines Outcome in Experimental Meningococcal DiseaseInfection and Immunity, 2010
- The elusive meningococcal meningitis serogroup: a systematic review of serogroup B epidemiologyBMC Infectious Diseases, 2010
- Characterization of fHbp , nhba ( gna2132 ), nadA , porA , and Sequence Type in Group B Meningococcal Case Isolates Collected in England and Wales during January 2008 and Potential Coverage of an Investigational Group B Meningococcal VaccineClinical and Vaccine Immunology, 2010
- Updated Postlicensure Surveillance of the Meningococcal C Conjugate Vaccine in England and Wales: Effectiveness, Validation of Serological Correlates of Protection, and Modeling Predictions of the Duration of Herd ImmunityClinical and Vaccine Immunology, 2010
- Evidence for Capsule Switching between Carried and Disease-Causing Neisseria meningitidis StrainsInfection and Immunity, 2009
- Meningococcal carriage and disease—Population biology and evolutionVaccine, 2009
- Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd ImmunityThe Journal of Infectious Diseases, 2008
- Emergency management of meningococcal disease: eight years onArchives of Disease in Childhood, 2007
- No evidence for capsule replacement following mass immunisation with meningococcal serogroup C conjugate vaccines in England and WalesThe Lancet Infectious Diseases, 2006